| inactivated Rift Valley Fever Vaccine . |
| |
| DISCRIPTION |
| |
| Rift Valley Fever inactivated vaccine ( Zagazig H501 strain) |
| inactivated by binary ethylenamine . |
| |
| COMPOSITION |
|
| The vaccine contains 106 TCID 50 /ml. The virus grows |
| on tissue culture cell line. |
|
| INDICATION |
|
| Protection of sheep, goat and cattle against Rift Valley |
| Fever disease. |
|
| DOSAGE AND METHOD OF USE |
|
| * The bottle content should be shaked well before use. |
| * Avoid exposure of vaccine to direct sunlight and heat. |
| * Sheep and goat should be vaccinated by 1ml. s/c while |
| cattle vaccinated 2ml. s/c. |
| * Only vaccinate healthy animal. |
|
| PROGRAME OF VACCINATION |
| |
| Sheep, goat and cattle should be vaccinated at 3-4 |
| months of age and then every six months. |
|
| STORAGE |
|
| The vaccine should be stored at ( 4 -8°C ). |
|
| EXPIARY DATE |
|
| One year from the date of manufacture. |
|
| PAKAGE |
|
| Available in bottle of 100 ml. |
|
